Si Qin - Net Worth and Insider Trading
Si Qin Net Worth
The estimated net worth of Si Qin is at least $154 Million dollars as of 2025-04-14. Si Qin is the Director of Tibet Rhodiola Pharmaceutical Holding Co and owns about 4,176,573 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) stock worth over $154 Million. Details can be seen in Si Qin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Si Qin has not made any transactions after 2008-01-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Si Qin
Si Qin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Si Qin owns 1 companies in total, including Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) .
Click here to see the complete history of Si Qin’s form 4 insider trades.
Insider Ownership Summary of Si Qin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | Director |
Si Qin Latest Holdings Summary
Si Qin currently owns a total of 1 stock. Si Qin owns 4,176,573 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) as of January 25, 2008, with a value of $154 Million.
Latest Holdings of Si Qin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | 4,176,573 | 36.89 | 154,073,778 |
Holding Weightings of Si Qin
Si Qin Form 4 Trading Tracker
According to the SEC Form 4 filings, Si Qin has made a total of 0 transactions in Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) over the past 5 years. The most-recent trade in Tibet Rhodiola Pharmaceutical Holding Co is the sale of 4,176,573 shares on January 25, 2008, which brought Si Qin around $12 Million.
Insider Trading History of Si Qin
- 1
Si Qin Trading Performance
GuruFocus tracks the stock performance after each of Si Qin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Si Qin is -40%. GuruFocus also compares Si Qin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Si Qin within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Si Qin's insider trading performs compared to the benchmark.
Performance of Si Qin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.85 | | | | | |
| Relative Return to S&P 500(%) | 2.75 | | | | | |
Si Qin Ownership Network
Ownership Network List of Si Qin
Ownership Network Relation of Si Qin
Si Qin Owned Company Details
What does Tibet Rhodiola Pharmaceutical Holding Co do?
Who are the key executives at Tibet Rhodiola Pharmaceutical Holding Co?
Si Qin is the Director of Tibet Rhodiola Pharmaceutical Holding Co. Other key executives at Tibet Rhodiola Pharmaceutical Holding Co include senior management Wang Bao Ming , senior management Cao Shu Zhen , and Supervisors Ren Bei Chen .
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tibet Rhodiola Pharmaceutical Holding Co Insider Transactions
Si Qin Mailing Address
Above is the net worth, insider trading, and ownership report for Si Qin. Currently GuruFocus does not have mailing address information for Si Qin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
